These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 27254275)

  • 61. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis.
    Harper CR; Jacobson TA
    Curr Opin Lipidol; 2007 Aug; 18(4):401-8. PubMed ID: 17620856
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Statin-associated muscle symptoms: position paper from the Luso-Latin American Consortium.
    Sposito AC; Faria Neto JR; Carvalho LS; Lorenzatti A; Cafferata A; Elikir G; Esteban E; Morales Villegas EC; Bodanese LC; Alonso R; Ruiz AJ; Rocha VZ; Faludi AA; Xavier HT; Coelho OR; Assad MH; Izar MC; Santos RD; Fonseca FA; Mello E Silva A; Silva PM; Bertolami MC;
    Curr Med Res Opin; 2017 Feb; 33(2):239-251. PubMed ID: 27776432
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
    Penson PE; Bruckert E; Marais D; Reiner Ž; Pirro M; Sahebkar A; Bajraktari G; Mirrakhimov E; Rizzo M; Mikhailidis DP; Sachinidis A; Gaita D; Latkovskis G; Mazidi M; Toth PP; Pella D; Alnouri F; Postadzhiyan A; Yeh HI; Mancini GBJ; von Haehling S; Banach M;
    J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1596-1622. PubMed ID: 35969116
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Statin-Associated Side Effects.
    Thompson PD; Panza G; Zaleski A; Taylor B
    J Am Coll Cardiol; 2016 May; 67(20):2395-2410. PubMed ID: 27199064
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of statin-intolerant patient.
    Arca M; Pigna G; Favoccia C
    Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Strategies to overcome statin intolerance.
    Agouridis AP; Nair DR; Mikhailidis DP
    Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):851-5. PubMed ID: 25786568
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Statins and the neuromuscular system: a neurologist's perspective.
    Argov Z
    Eur J Neurol; 2015 Jan; 22(1):31-6. PubMed ID: 25495398
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Statin-Associated Bilateral Foot Myopathy.
    Baggett MC; Nykamp D
    J Pharm Pract; 2020 Dec; 33(6):899-902. PubMed ID: 31248326
    [TBL] [Abstract][Full Text] [Related]  

  • 69. An assessment of statin safety by muscle experts.
    Thompson PD; Clarkson PM; Rosenson RS;
    Am J Cardiol; 2006 Apr; 97(8A):69C-76C. PubMed ID: 16581332
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Overcoming toxicity and side-effects of lipid-lowering therapies.
    Wilkinson MJ; Laffin LJ; Davidson MH
    Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Statin myopathy: a review of recent progress.
    Mammen AL; Amato AA
    Curr Opin Rheumatol; 2010 Nov; 22(6):644-50. PubMed ID: 20827205
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Statin induced myopathy.
    Frank RE
    J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
    Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK
    Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Decoding the Intricacies of Statin-Associated Muscle Symptoms.
    Rastegar TF; Khan IA; Christopher-Stine L
    Curr Rheumatol Rep; 2024 Jul; 26(7):260-268. PubMed ID: 38575845
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The nocebo effect in the context of statin intolerance.
    Tobert JA; Newman CB
    J Clin Lipidol; 2016; 10(4):739-747. PubMed ID: 27578103
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.
    Mitchell D; Guertin JR; Iliza AC; Fanton-Aita F; LeLorier J
    Mol Diagn Ther; 2017 Feb; 21(1):95-105. PubMed ID: 27798813
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Statin myopathy as a metabolic muscle disease.
    Phillips PS; Haas RH
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):971-8. PubMed ID: 18666847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.